Navigation Links
Navitas Names Dr. Dean Gesme as Medical Director
Date:10/17/2007

DENVER, Oct. 17 /PRNewswire/ -- Navitas Cancer Rehabilitation Centers of America, Inc. (Navitas), the market leader in providing integrated and comprehensive cancer rehabilitation services, is pleased to announce the appointment of Dean H. Gesme, Jr., M.D. as Corporate Medical Director.

In addition to currently providing care as a medical oncologist in the Minneapolis/St. Paul area, Dr. Gesme has served as the Past-Chair of the National Coalition for Cancer Survivorship and is Past-Chair of the Clinical Practice Committee of the American Society of Clinical Oncology. He has been the Oncology Representative on the AMA CPT Advisory Panel dealing with physician coding, and payment issues. Dr. Gesme is board certified in Internal Medicine, Medical Oncology, and Medical Management. Dr. Gesme attended medical school at the University of Iowa and completed his residency training in Internal Medicine in San Francisco and his fellowship in Medical Oncology at the University of Minnesota.

"Navitas has a tremendous opportunity to serve cancer survivors and Dr. Gesme is perfectly suited to provide medical leadership to this vision," shared Paul Barnes, Ph.D., President and CEO for Navitas. "Dean has devoted his career to the patient advocacy community as well to the treatment of cancer patients. We are fortunate to have him join our management team at Navitas.

"I have been impressed by the clinical basis of the cancer rehabilitation program at Navitas," Dr. Gesme stated. "I look forward to the day where rehabilitation services for cancer patients are as much the standard of care as is true for cardiac and other areas of medicine. Cancer patients deserve no less. I look forward to contributing to the clinical research efforts at Navitas to make that happen."

About Navitas Cancer Rehabilitation Centers of America

Founded in 2003, Navitas Cancer Rehabilitation Centers of America (http://www.navitasinc.com) developed an evidence-based approach to providing rehabilitation and supportive therapies to people with cancer. Navitas provides these services on a free-standing basis as well as through community-based and hospital-based oncology centers and practices. The Navitas vision is to make supportive and rehabilitation services a standard component of the cancer treatment plan through the development of a robust, multi-disciplinary clinical program and demonstrated outcomes for patients and physicians. Navitas is headquartered in Denver, Colorado.

http://www.navitasinc.com

Media Contact:

Shaun Burns

303-865-7840

sburns@navitasinc.com


'/>"/>
SOURCE Navitas Cancer Rehabilitation Centers of America
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Wisconsin IT association names Gee president, CEO
2. Quintessence Biosciences names new president
3. CDW names VP to handle Berbee merger
4. NimbleGen names CFO with capital-raising past
5. Cisco names Berbee a top partner of 2005
6. Cisco names Inacom most innovative partner
7. UW-Madison medical school names new dean
8. GE Healthcare names new CEO
9. Bruker AXS names new leadership
10. Sonic Foundry names new senior vice president
11. MyWeather names new president, marketing officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced that ... SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 ... cross the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):